Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Viruses|March 21, 2019
Cat and Mouse: HIV Transcription in Latency, Immune Evasion and Cure/Remission StrategiesAurélie Delannoy, Mikaël Poirier, Brendan Bell
RNA (New York, N.Y.)|July 28, 2021
SRSF10: an atypical splicing regulator with critical roles in stress response, organ development, and viral replicationLulzim Shkreta, Aurélie Delannoy, Anna Salvetti, et al.
RNA (New York, N.Y.)|September 9, 2024
Regulatory interplay between SR proteins governs CLK1 kinase splice variants productionLulzim Shkreta, Aurélie Delannoy, Johanne Toutant, et al.
Molecular Therapy. Nucleic Acids|February 24, 2026
RNA-based discovery and correction of splicing defects caused by POLR3A missense mutationsLulzim Shkreta, Aurélie Delannoy, Johanne Toutant, et al.
Cell Death & Disease|January 24, 2018
BIM and NOXA are mitochondrial effectors of TAF6δ-driven apoptosisAurélie Delannoy, Emmanuelle Wilhelm, Sebastian Eilebrecht, et al.
Plos One|July 16, 2014
Alternative splicing of TAF6: downstream transcriptome impacts and upstream RNA splice control elementsCatherine Kamtchueng, Marie-Éve Stébenne, Aurélie Delannoy, et al.
NAR Cancer|July 28, 2021
A novel class of inhibitors that target SRSF10 and promote p53-mediated cytotoxicity on human colorectal cancer cellsMuhammad Sohail, Lulzim Shkreta, Johanne Toutant, et al.
Oncotarget|May 16, 2024
The anticancer potential of the CLK kinases inhibitors 1C8 and GPS167 revealed by their impact on the epithelial-mesenchymal transition and the antiviral immune responseLulzim Shkreta, Johanne Toutant, Aurélie Delannoy, et al.
Pageof 1